Clinical trial
Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine…
NCT00406783 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00406783 |
|---|---|
| Title | Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) |
| Official title | Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter/Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis Who Meet the Criteria for Intermittent Allergic Rhinitis (IAR) |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal, Perennial |
| Intervention type | Drug |
| Interventions | 5-mg Desloratadine, Placebo |
| Enrollment | 547 |
| Start date | Aug 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Dec 4, 2006 |
| Last update posted | May 20, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: